MiRNA-616 aggravates the progression of bladder cancer by regulating cell proliferation, migration and apoptosis through downregulating SOX7.

Zhao X, Li D, Zhao ST, Zhang Y, Xu A, Hu YY, Fang Z.

DOI: 10.26355/eurrev_201911_19423
Published: 2019-11-01
Container: Eur Rev Med Pharmacol Sci
Publisher: Not recorded
Open access: no

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.26355/eurrev_201911_19423,
  title = {MiRNA-616 aggravates the progression of bladder cancer by regulating cell proliferation, migration and apoptosis through downregulating SOX7.},
  author = {Zhao X and  Li D and  Zhao ST and  Zhang Y and  Xu A and  Hu YY and  Fang Z.},
  year = {2019},
  journal = {Eur Rev Med Pharmacol Sci},
  doi = {10.26355/eurrev_201911_19423},
  url = {https://doi.org/10.26355/eurrev_201911_19423}
}

RIS

TY  - JOUR
TI  - MiRNA-616 aggravates the progression of bladder cancer by regulating cell proliferation, migration and apoptosis through downregulating SOX7.
AU  - Zhao X
AU  -  Li D
AU  -  Zhao ST
AU  -  Zhang Y
AU  -  Xu A
AU  -  Hu YY
AU  -  Fang Z.
PY  - 2019
JO  - Eur Rev Med Pharmacol Sci
DO  - 10.26355/eurrev_201911_19423
UR  - https://doi.org/10.26355/eurrev_201911_19423
ER  -

APA

X, Z., D, L., ST, Z., Y, Z., A, X., YY, H., & Z., F. (2019). MiRNA-616 aggravates the progression of bladder cancer by regulating cell proliferation, migration and apoptosis through downregulating SOX7.. Eur Rev Med Pharmacol Sci. https://doi.org/10.26355/eurrev_201911_19423

Source records

europe-pmc · retrieved 2026-09-25T14:49:41.780Z